Status:
COMPLETED
Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Rhinitis, Allergic, Seasonal
Rhinitis, Allergic, Perennial
Eligibility:
All Genders
3-15 years
Brief Summary
The purpose of this study is to collect information on unexpected adverse reactions (ADRs), how often ADRs occur, and factors that can affect the safety and effectiveness of Claritin (loratadine) when...
Eligibility Criteria
Inclusion
- Pediatric patients aged 3 to 15 years who are treated with Claritin for any of the following reasons: allergic rhinitis, urticaria, itching due to skin disease (eczema, dermatitis, or pruritus cutaneous)
Exclusion
- (None)
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
1003 Patients enrolled
Trial Details
Trial ID
NCT00762983
Start Date
March 1 2008
End Date
February 1 2009
Last Update
February 13 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.